Slaughter and May and Allen & Overy (A&O) have taken lead roles on GlaxoSmithKline’s (GSK’s) €470m (£393m) divestment of a portfolio of European over-the-counter (OTC) healthcare products to Omega Pharma. A&O took the lead for Dutch OTC specialist Omega, fielding a five-partner team led by Antwerp M&A partner Hans Kets, with Frankfurt corporate partner Matthias Horn and employment partner Hans-Peter Low also advising.
April 04, 2012 at 07:03 PM
1 minute read
The original version of this story was published on Legalweek
Slaughter and May and Allen & Overy (A&O) have taken lead roles on GlaxoSmithKline’s (GSK’s) €470m (£393m) divestment of a portfolio of European over-the-counter (OTC) healthcare products to Omega Pharma.
A&O took the lead for Dutch OTC specialist Omega, fielding a five-partner team led by Antwerp M&A partner Hans Kets, with Frankfurt corporate partner Matthias Horn and employment partner Hans-Peter Low also advising.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
